Pascale Palassin

Statistics

Publications

Citations

254

H-Index

Active since

2022

Affiliations

Centre Hospitalier Universitaire de Montpellier(Current)

Institute for Regenerative Medicine & Biotherapy

Université de Montpellier

Inserm

Institut de Recherche en Cancérologie de Montpellier

Pascale Palassin is an author at Centre Hospitalier Universitaire de Montpellier specializing in immune checkpoint inhibitors, checkpoint inhibitor therapy, and medicine.

ORCID

Publications per year

2022–2024

Publications

Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort

Lina Hountondji, Christophe Ferreira De Matos, Fanny Lebossé et al. · JHEP Reports · 2023 · 84 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

Naïm Ouldali, Haleh Bagheri, Francesco Salvo et al. · The Lancet Regional Health - Europe · 2022 · 69 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16

Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study

Laurine Diaz, Benjamin Jauzelon, Anne-Charlotte Dillies et al. · Journal of Clinical Medicine · 2023 · 30 citations · Full text

Medicine, Hematology, Immunology +16

Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data

Lucy Meunier, Lina Hountondji, Hélène Jantzem et al. · Clinical Gastroenterology and Hepatology · 2023 · 25 citations · Full text

Life Sciences, Immunology, Oncology +13

Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database

M. Martin, Hoan-My Nguyen, C. Beuvon et al. · Cancers · 2022 · 17 citations · Full text

Life Sciences, Hematology, Pharmacology +15

1–5 of 7